Accelerating Discovery & Impact
A newer-generation clot-busting drug called tenecteplase outperforms the traditional treatment for ischemic strokes in several key areas, according to a study by Dell Med neurologists.
University of Texas researchers found that a five-day delay between identifying a case and isolating contacts was the Achilles’ heel of a contact tracing program in a large U.S. city.
Providing caregivers easy access to produce and flexible resources can lead to improvements in kids’ diets in a short time, according to a new study from Dell Med researchers.
Almost 90% of Texas women whose pregnancies were covered by public insurance were uninsured at some point in the first year after delivery, according to a new study from researchers at The University of Texas at Austin.
A newer clot-busting medication may dramatically reduce the risk of serious complications from bleeding into the brain after stroke treatment, according to preliminary research at Dell Med.
The center will conduct clinical research to better understand the potential for drugs such as psilocybin, MDMA, ibogaine and ayahuasca to treat mental health disorders.
A Dell Med-U.S. Department of Veterans Affairs study showed that sexual assault and harassment could have a generational effect on military families.
Population health researchers at Dell Med found that kids living in Travis County are hospitalized for asthma at a significantly higher rate than U.S. children overall.
An Interdisciplinary team led by Dell Med and the Steve Hicks School of Social Work created a digital reporting and surveillance system to track drug overdoses statewide.
University of Texas researchers discovered a new mathematical modeling technique that can accurately predict the response of tumors in breast cancer patients to treatments such as chemotherapy.